DNA X, Inc. (SONM): Capital Expenditures

Annual figures by period end, from SEC filings.

$214.0K
Year ended 2024-12-31
+66.9%
3-year compound annual growth
-26.4%
5-year compound annual growth
$992.0K2018-12-31: $787.0K2019-12-31: $992.0K2020-12-31: $11.0K2021-12-31: $46.0K2022-12-31: $8.0K2023-12-31: $36.0K2024-12-31: $214.0K$214.0K
2018-12-31 Capital Expenditures (USD) 2024-12-31
Period endedCapital ExpendituresChange YoYSource filing
2024-12-31$214.0K+494.4%2026-04-15, From 2024-01-01
2023-12-31$36.0K+350.0%2025-03-31, From 2023-01-01
2022-12-31$8.0K-82.6%2024-03-27, From 2022-01-01
2021-12-31$46.0K+318.2%2023-03-20, From 2021-01-01
2020-12-31$11.0K-98.9%2022-06-29, From 2020-01-01
2019-12-31$992.0K+26.0%2021-03-18, From 2019-01-01
2018-12-31$787.0Kn/a2020-03-27, From 2018-01-01